The industry wants the ability to make bolder health claims and to get the government and private insurers to pay for its products — as they do FDA-approved drugs.

Limiting mifepristone access, changing Title X rules and implementation of the Emergency Medical Treatment and Labor Act are ...

The U.S. Department of Health and Human Services has extended the decision deadline on updating the 'healthy' nutrient ...

Robert F. Kennedy Jr. is making moves that could affect immunization uptake and policy in the U.S., while Oracle submits a ...

Dame Emma Walmsley prides herself on her tenacity. It is something the GSK chief says she inherited from her late father, a ...

Trump’s tariff threats and Kennedy’s anti-vaccine stance makes US a hostile environment for pharma companies ...

The coming weeks and months will offer clues about the direction Kennedy will take US vaccine policy–signs as to whether ...

Courtney Gaine, president and CEO of the Sugar Association, explains the latest in nutritional policy, including what Robert ...

Beef tallow, used primarily for cooking but also in products such as soap and biodiesel, has been championed by a subset of ...

People raise their hands after being asked how many people in the room are in favor of HB81, a bill that bans fluoride in ...